Modular pooled discovery of synthetic knockin sequences to program durable cell therapies

Franziska Blaeschke1, Yan Yi Chen1, Ryan Apathy1

  • 1Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.

Cell
|September 15, 2023
PubMed
Summary

A new screening platform, ModPoKI, enables rapid comparison of genetic modifications to improve T-cell therapies. It identified a transcription factor construct (TFAP4) that enhances CAR-T cell function against cancer.